Additional Support & Downloadable Resources for You

The following resources offer additional information and support throughout your treatment journey with GOMEKLI® (mirdametinib).

Enrollment Form

SpringWorks CareConnections® 
Enrollment Form

Work with your doctor to complete this form so you can start taking advantage of support that may be available to you through SpringWorks CareConnections.

Download English VersionDownload Spanish Version

Patient Brochure

SpringWorks CareConnections
Patient Brochure

Discover the support available from SpringWorks CareConnections throughout your treatment journey with GOMEKLI.

Download English VersionDownload Spanish Version

Navigating Health Insurance Brochure

Navigating Health Insurance Brochure

Learn about some of the different types of health insurance as well as select terms related to obtaining GOMEKLI coverage.

Download

Navigating Health Insurance as a Young Adult Brochure

Navigating Health Insurance as a Young Adult Brochure

Understand how and when your health insurance may change as a young adult and how you can advocate for your own healthcare.

Download

Sample Letter to Employer

Sample Letter to Employer

Refer to this example when writing to your employer regarding a coverage denial of GOMEKLI when an Alternative Funding Program (AFP) is involved.

Download

Sample Letter to Health Insurance Company

Sample Letter to Health Insurance Company

Refer to this example when writing to your health insurance provider regarding a coverage denial of GOMEKLI when an AFP is involved.

Download

Quarterly Patient Newsletter

Quarterly Patient Newsletter

Stay informed and empowered with our quarterly newsletter, featuring helpful resources, lifestyle tips for managing your condition and treatment, ways to connect with your community, and insights from our Nurse Advocates.

Download

How Health Insurance Changes May Impact You Brochure

How Health Insurance Changes May Impact You Brochure

Understand how health insurance plan changes may impact you and learn to make informed decisions when selecting a new health insurance plan.

Download

We can help connect you to other useful resources:

Gomekli patient site

Visit the GOMEKLI patient site to learn more about GOMEKLI, including possible side effects, how to take GOMEKLI, and more.

Organizations

Organizations that can offer helpful information and support.*

Resources

Helpful resources that can offer additional support.

 

*SpringWorks Therapeutics is providing these websites and resources to help patients find more information about their condition, but their inclusion does not represent an endorsement or a recommendation from SpringWorks Therapeutics for any group or organization. Any organization listed is independent of SpringWorks Therapeutics.

Staying on track with GOMEKLI support is always within reach! SpringWorks has partnered with Medisafe, the #1 medication management app to give GOMEKLI patients a free resource in the GOMEKLI Digital Companion

Support & Resources for You

It’s important to take GOMEKLI as directed by your care team. We created resources to help you start and stay on track! You can use tools from the GOMEKLI starter kit, like the pillbox and dry-erase calendar, to help stay on track. Or download the GOMEKLI Digital Companion through Medisafe

Click here to learn more

If you have been prescribed GOMEKLI, ask your doctor to help you fill out the patient form and enroll in the SpringWorks CareConnections Patient Support Program so you can have access to support

Enroll

Have Questions?

Call SpringWorks
CareConnections today

844-CARES-55
(844-227-3755)

Monday-Friday
8 AM-8 PM ET

© 2026 Merck KGaA, Darmstadt, Germany and/or its affiliates. All rights reserved.

OGSIVEO, GOMEKLI, PIMJETMI, and SpringWorks CareConnections are registered trademarks of Merck KGaA, Darmstadt, Germany and/or its affiliates. All other trademarks are the property of their respective owners.

EMD Serono, Inc. and SpringWorks Therapeutics, Inc. are healthcare companies of Merck KGaA, Darmstadt, Germany.

US-GOM-01893  11/26

This site is intended for U.S. audiences only.

This site is intended for U.S. audiences only.

Cookie Settings